Veritas Intercontinental appoints Bibiana Palao Uceda 8 de mayo de 2019 by admin2104 Leave a Comment Veritas Intercontinental Europe & Latam, subsidiary of Veritas Genetics, The Genome Company, appoints Bibiana Palao Uceda as VP Medical Science Liaison. She has a Bachelor of Pharmacy from the Complutense University of Madrid, Bibiana Palao’s curriculum is completed with a Postgraduate in Medical Genetics by the Institute of Genomic Medicine and a Master’s Degree in Medical Science Liaison (MSL) by the Center for Advanced Studies of the Pharmaceutical Industry (CESIF). Also, she has an Expert Degree in Personalized Nutrition from the European University of the Atlantic. As director of the Scientific Department of Veritas Int., Bibiana Palao will be responsible for the development of the product information of the of Veritas Int., the coordination of the group of experts for the development of new specific tests. In addition, she will be directing the service of support and scientific consultations and training programs for both employees and the commercial team. Prior to joining Veritas, Bibiana Palao was responsible for the Scientific Dept. of Corporate Innovation at Synlab Laboratories and also held the position of Technical and Scientific Director of Labec Pharma SL. About Veritas Intercontinental Veritas Intercontinental is the international subsidiary of Veritas Genetics, The Genome Company, which operates in Europe, Latin America, Japan and UAE. Its mission is to promote whole genome and offer people information that empowers them to maximize the quality and duration of their lives and their families, changing the way in which the world conceives genetics. Veritas was the first company to offer whole genome sequencing and interpretation to consumers and their physicians and leads the field of genetics, expanding the limits of science and technology and reducing the cost of the genome. Veritas was founded in 2014 by leaders in genomics at the Harvard Medical School and operates worldwide from its offices in the United States, Europe and China. The company has been recognized by MIT Technology Review as one of the 50 Smartest Companies in 2016 and 2017, by Fast Company as one of the most innovative healthcare companies in the world in 2018, and by CNBC as one of the Disruptor 50 companies in 2018. For more information about our counseling service, our genetic tests or any questions you may have, contact us.